Akebia Therapeutics, Inc. (AKBA) NASDAQ
1.46
+0.06(+4.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.46
+0.06(+4.29%)
Currency In USD
| Market Cap | 414.02M |
| Enterprise Value | 445.48M |
| P/E Ratio | -72.49 |
| PEG Ratio | -0.96 |
| Price/Sales Ratio | 1.66 |
| Price/Book Ratio | 11.88 |
| Enterprise/Revenue | 1.79 |
| Enterprise/EBITDA | 19.45 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.02 |
| Operating Margin | 0.1 |
| Return On Assets | -0.01 |
| Return On Equity | -0.17 |
| Revenue | 236.2M |
| Revenue/Share | 0.89 |
| Gross Profit | 196.73M |
| EBITDA | 21.73M |
| Net Income | -5.35M |
| Diluted EPS | -0.02 |
| Total Cash | 184.84M |
| Total Cash/Share | 0.7 |
| Total Debt | 216.3M |
| Total Debt/Equity | 6.63 |
| Current Ratio | 1.13 |
| Book Value Per Share | 0.12 |
| 52-Week Change | -35.4 |
| 52-Week High | 4.08 |
| 52-Week Low | 1.14 |
| Moving Average 50 Days | 1.37 |
| Moving Average 200 Days | 2.49 |
| Average Volume | 3.22M |
| Shares Outstanding | 267.88M |
| % Held by Institutions | 44.77 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |